Survodutide

Survodutide is a GLP-1 and glucagon receptor dual agonist developed independently of the oxyntomodulin-derived compounds, which is why it is worth studying alongside rather than instead of mazdutide: the two reach a similar receptor combination by different structural routes, and the differences show up in the pharmacokinetics. The glucagon arm is the reason this pairing draws attention, since it introduces an energy-expenditure component absent from GIP-based dual agonists.

Supplied lyophilised per vial. Store sealed at -20 C, reconstitute with bacteriostatic water, keep the reconstituted solution refrigerated and away from light, and avoid freeze-thaw cycles.

Most comparative protocols also include tirzepatide and retatrutide. See our lab reports for purity data.

For laboratory research use only.

Currently unavailable

Sold strictly for in-vitro laboratory and research use only. Not for human or veterinary consumption.